September 24, 2012
The landmark iPrEx study demonstrated the feasibility of taking Truvada for pre-exposure prophylaxis (PrEP). It also demonstrated that success depends on adherence. The trial participants receiving Truvada had a 44% reduced risk of becoming infected overall, but those who were actually taking the medication had a 92% risk reduction.
The iPrEx team have now turned to the question, how often one has to take the pill to remain protected. Testing at 2, 4, and 7 pills a week, they found the minimum number of pills per week is 4.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.